ELEVAI Labs Inc.

ELEVAI Labs Inc.

Biotechnology Research

Newport , California 3,000 followers

Leaders in stem cell exosome technology developing next-generation anti-aging skincare for the medical aesthetic market.

About us

ELEVAI Labs (NASDAQ: ELAB) specializes in medical aesthetics and biopharmaceutical drug development, focusing on aesthetic innovations for skin, and treatments tied to obesity and metabolic health. Driven by a commitment to scientific research, we aim to transform personal health and beauty. For more information, please visit www.elevailabs.com. ELEVAI Biosciences Inc., an Elevai Labs company, is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Our lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. For more information, please visit www.elevaibio.com. ELEVAI Skincare Inc., an Elevai Labs company, is a medical aesthetics company developing and commercializing cutting-edge physician-dispensed skin and hair care applications. Elevai develops cosmetic products for the physician-dispensed market, with a focus on leveraging novel proprietary science-backed technologies, including its stem cell exosome technology. For more information, please visit www.elevaiskincare.com.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Newport , California
Type
Public Company
Founded
2020
Specialties
Stem Cells, Exosomes, Skincare, Aesthetics, Physician Dispensed, Regenerative Skincare, Dermatology, Plastic Surgery, Post-Procedure, Skin Health, Growth Factors, and Ethical Sourcing

Locations

Employees at ELEVAI Labs Inc.

Updates

Similar pages

Browse jobs

Funding

ELEVAI Labs Inc. 3 total rounds

Last Round

Post IPO equity

US$ 8.0M

See more info on crunchbase